Do Analysts Agree Monday on AcelRx Pharmaceuticals Inc (ACRX) Stock's Target Price?

Monday, September 13, 2021 11:58 AM | InvestorsObserver Analysts

Mentioned in this article

Do Analysts Agree Monday on AcelRx Pharmaceuticals Inc (ACRX) Stock's Target Price?

InvestorsObserver is giving AcelRx Pharmaceuticals Inc (ACRX) an Analyst Rating Rank of 75, meaning ACRX is ranked higher by analysts than 75% of stocks. The average price target for ACRX is $6 and analyst’s rate the stock as a Strong Buy.

Wall Street analysts are rating ACRX a Strong Buy today. Find out what this means to you and get the rest of the rankings on ACRX!

See Full ACRX Report

Why are Analyst Ratings Important?

Though analyst projections should not be your only resource when determining your position on a stock, it can be a very useful tool. Analysts follow sectors/industries in-depth and tend to know how local and global conditions tend to affect demand and prices. Many analysts even participate in conference calls where they can get information to better make sense of the numbers. InvestorsObserver averages the ratings provided by analysts and then ranks their score as a percent against the market. This allows you to compare stocks in a more comprehensive fashion than with the typical buy/sell/hold ranking.

What's Happening With AcelRx Pharmaceuticals Inc Stock Today?

AcelRx Pharmaceuticals Inc (ACRX) stock is trading at $1.03 as of 11:56 AM on Monday, Sep 13, a gain of $0.01, or 0.98% from the previous closing price of $1.02. The stock has traded between $1.00 and $1.03 so far today. Volume today is less active than usual. So far 361,497 shares have traded compared to average volume of 1,262,552 shares. Click Here to get the full Stock Report for AcelRx Pharmaceuticals Inc stock.